Vitura Health Past Earnings Performance

Past criteria checks 2/6

Vitura Health has been growing earnings at an average annual rate of 58.2%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 58.1% per year. Vitura Health's return on equity is 8.5%, and it has net margins of 2.8%.

Key information

58.2%

Earnings growth rate

96.1%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate58.1%
Return on equity8.5%
Net Margin2.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Vitura Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:1CE0 Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241244290
31 Mar 241226270
31 Dec 231209250
30 Sep 2311912230
30 Jun 2311714200
31 Mar 2310712190
31 Dec 229710190
30 Sep 22828170
30 Jun 22676160
31 Mar 22545120
31 Dec 2142580
30 Sep 2132360
30 Jun 2122150
31 Mar 2115050
31 Dec 207-250
30 Sep 204-350
30 Jun 200-440
31 Mar 200-440
31 Dec 190-430
30 Sep 190-330
30 Jun 190-330
30 Jun 180000
30 Jun 170000

Quality Earnings: 1CE0 has high quality earnings.

Growing Profit Margin: 1CE0's current net profit margins (2.8%) are lower than last year (11.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1CE0 has become profitable over the past 5 years, growing earnings by 58.2% per year.

Accelerating Growth: 1CE0's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 1CE0 had negative earnings growth (-74.6%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (28.7%).


Return on Equity

High ROE: 1CE0's Return on Equity (8.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies